Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
Carbonic Anhydrase IX: A Renewed Target for Cancer Immunotherapy.
Cancers (Basel). 2022 Mar 9;14(6):1392. doi: 10.3390/cancers14061392.
Cancers (Basel). 2022.
PMID: 35326544
Free PMC article.
Review.
CAIX expression is restricted to a few sites in healthy tissues, positioning this molecule as a strategic target for cancer immunotherapy. In this review, we summarized preclinical and clinical data of immunotherapeutic strategies based on monoclonal antibodies (mAbs), fus …
CAIX expression is restricted to a few sites in healthy tissues, positioning this molecule as a strategic target for cancer immunothe …
CMTM6 and CMTM7: New leads for PD-L1 regulation in breast cancer cells undergoing EMT.
Xiao M, Duhem C, Chammout A, Berchem G, Janji B.
Xiao M, et al.
J Cell Biochem. 2022 Jun;123(6):1025-1031. doi: 10.1002/jcb.30273. Epub 2022 May 16.
J Cell Biochem. 2022.
PMID: 35575054
Free PMC article.
Programmed death-ligand 1 (PD-L1) expression has long been used as a biomarker to stratify patients with cancer who will benefit from anti-PD-1/PD-L1 immunotherapy. However, the use of PD-L1 as a biomarker to guide treatment decisions has recently been called into question …
Programmed death-ligand 1 (PD-L1) expression has long been used as a biomarker to stratify patients with cancer who will benefit from …
Item in Clipboard
Cite
Cite